Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY:SYK)

388.56 -1.38 (-0.35%)
Official Closing Price Updated: 4:10 PM EDT, Sep 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
If You Could Only Hold 3 Investments for Life, Consider These
Discover 3 must-own investments for lifelong growth. From dividend stocks to a market-beating ETF, these picks offer stability, returns, and long-term wealth. 
Via MarketBeat
Topics ETFs Economy Retirement
Here's How Much $100 Invested In Stryker 15 Years Ago Would Be Worth Today
 
Via Benzinga
3 Growth Stocks to Buy and Hold Forever
Via The Motley Fool
Medical Devices & Supplies - Diversified Stocks Q4 Teardown: Stryker (NYSE:SYK) Vs The Rest
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at medical devices & supplies - diversified... 
Via StockStory
Q4 Earnings Roundup: Baxter (NYSE:BAX) And The Rest Of The Medical Devices & Supplies - Diversified Segment
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how medical devices & supplies - diversified stocks fared in Q4,... 
Via StockStory
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today
 
Via Benzinga
Analyst Expectations For Stryker's Future
 
Via Benzinga
Q4 Earnings Highs And Lows: Neogen (NASDAQ:NEOG) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Neogen (NASDAQ:NEOG) and its peers. 
Via StockStory
Stryker completes acquisition of Inari Medical, Inc., providing entry into the high-growth peripheral vascular segment
From Stryker Corporation
Via GlobeNewswire
Baxter Earnings: What To Look For From BAX
Healthcare company Baxter International (NYSE:BAX) will be reporting earnings tomorrow morning. Here’s what investors should know. 
Via StockStory
Stryker to participate in Citi’s 2025 Unplugged Medtech and Life Sciences Access Day
From Stryker Corporation
Via GlobeNewswire
Peering Into Stryker's Recent Short Interest
 
Via Benzinga
$100 Invested In Stryker 10 Years Ago Would Be Worth This Much Today
 
Via Benzinga
A Glimpse Into The Expert Outlook On Stryker Through 14 Analysts
 
Via Benzinga
What To Expect From Baxter’s (BAX) Q4 Earnings
Healthcare company Baxter International (NYSE:BAX) will be announcing earnings results tomorrow morning. Here’s what investors should know. 
Via StockStory
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Stryker announces Allan Golston will retire from Board of Directors
From Stryker Corporation
Via GlobeNewswire
Stryker Earnings Report: Q4 Overview
 
Via Benzinga
Stryker Earnings Review: Q4 Summary
 
Via Benzinga
Stryker Earnings Analysis: Q4 Recap
 
Via Benzinga
Q4 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Boston Scientific (NYSE:BSX)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Boston Scientific (NYSE:BSX) and the best... 
Via StockStory
Jim Cramer: This Health Care Stock Is A 'Winner,' Buy Bitcoin Instead Of Coinbase
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying AbbVie Inc. (NYSE:ABBV), saying it's “just a gem” and a “winner.”  He added, “I can't believe the stock dropped so much.” 
Via Benzinga
Stryker declares an $0.84 per share quarterly dividend
From Stryker Corporation
Via GlobeNewswire
Stryker (NYSE:SYK) Posts Better-Than-Expected Sales In Q4
Medical technology company Stryker (NYSE:SYK) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 10.7% year on year to $6.44 billion. Its non-GAAP profit of $4.01 per... 
Via StockStory
Stryker Q4 Earnings Assessment
 
Via Benzinga
Stryker's Strategic Moves Impress Analysts, Spine Implant Sale and NARI Deal Set to Drive Future Growth
Wall Street analysts upgraded Stryker Corp (NYSE: SYK) after its Q4 report beat expectations, with strong sales and earnings growth projected for 2025. 
Via Benzinga
Starbucks To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Wednesday
 
Via Benzinga
US Futures Point To Cautious Start As Investors Await Fed's Rate Decision: Tesla, Microsoft, Meta Among Stocks In Focus Ahead Of Earnings
U.S. stock futures were mixed ahead of the crucial earnings from key U.S. technology companies and the Fed's expected pause on rate cuts. 
Via Benzinga
Topics Economy
Tesla, Starbucks And 3 Stocks To Watch Heading Into Wednesday
 
Via Benzinga
Stryker Undercuts Breakout On Sales Deal, Despite Quarterly Beat
Stryker stock dipped late Tuesday after the medtech company beat forecasts, but announced its plan to divest the U.S. spinal business. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.